IDiyas

For the Inventor, By the Inventor

Berkshire, United Kingdom

Zogenix International Limited


USPTO Granted Patents = 21



Trademarks = 2

Forward Citations = 155

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Brooks M Boyd (10 out of 17 patents)

silverMedal Stephen J Farr (7 out of 31 patents)

bronzeMedal Marc W Andersen (4 out of 14 patents)

4.  Bradley S Galer (4 out of 17 patents)

5.  Derek John Londesbrough (4 out of 11 patents)

6.  Parthena Martin (3 out of 3 patents)

7.  Carl L Faingold (2 out of 2 patents)

8.  Richard Alistair Balfour Stewart (2 out of 3 patents)

9.  Anthony Clarke (2 out of 7 patents)

10.  Khawla Abu-Izza (2 out of 2 patents)

11.  David Hickman (2 out of 2 patents)

12.  Glenn Arthur Morrison (2 out of 9 patents)

13.  Stephan J Farr (1 out of 1 patent)

14.  Bret Megargel (1 out of 1 patent)

15.  Derek Londesbrough (0 patent)


21 patents:

1. 12144787 - Method of treating patients with a mutation in cyclin-dependent kinase-like 5 (CDKL5) (2024-11-19),
2. 11786487 - Formulation for inhibiting formation of 5-HTagonists and methods of using same (2023-10-17),
3. 11759440 - Formulation for inhibiting formation of 5-HTagonists and methods of using same (2023-09-19),
4. 11673852 - Metabolism resistant fenfluramine analogs and methods of using the same (2023-06-13),
5. 11634377 - Fenfluramine compositions and methods of preparing the same (2023-04-25),
6. 11612574 - Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (2023-03-28),
7. 11571397 - Compositions and methods for treating seizure-induced sudden death (2023-02-07),
8. 11458111 - Ketogenic diet compatible fenfluramine formulation (2022-10-04),
9. 11406606 - Formulation for inhibiting formation of 5-HT2B agonists and methods of using same (2022-08-09),
10. 11325882 - Metabolism resistant fenfluramine analogs and methods of using the same (2022-05-10),
11. 11040018 - Formulation for inhibiting formation of 5-HT2B agonists and methods of using same (2021-06-22),
12. 10952976 - Compositions and methods for treating respiratory depression with fenfluramine (2021-03-23),
13. 10950331 - Control system for control of distribution of medication (2021-03-16),
14. 10947183 - Fenfluramine compositions and methods of preparing the same (2021-03-16),
15. 10689324 - Metabolism resistant fenfluramine analogs and methods of using the same (2020-06-23),
Zogenix International Limited is a pharmaceutical company dedicated to developing and commercializing transformative therapies for patients with rare diseases. With a focus on developing innovative treatments, Zogenix aims to improve the lives of patients and their families. Learn more about Zogenix and their mission on their website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

21 Patents

#9 in Berkshire

#836 in United Kingdom

#29,031 in the World

...
Berkshire, United Kingdom

Zogenix International Limited

Forward Citations = 155

18 inventors:

goldMedal Brooks M Boyd (10 out of 17 patents)

silverMedal Stephen J Farr (7 out of 31 patents)

bronzeMedal Marc W Andersen (4 out of 14 patents)

4.  Bradley S Galer (4 out of 17 patents)

5.  Derek John Londesbrough (4 out of 11 patents)

Please report any incorrect information to support@idiyas.com
Loading…